Vegamax

11/04/2026

19/01/2026

📊 VEGA Weekly Report | A steady market with selective cost-driven firmness.
Raw material pressure, tight spot supply, and cautious downstream demand continue to shape short-term trends.

🔍 This week’s focus:
• Niacin & niacinamide supported by cost increases
• Isoleucine tightens amid limited spot supply
• APIs remain under pressure with cautious buying

👉 Full market insights here:
http://www.vegapharma.com/index/china/index.html

09/01/2026

🔎 Upward signals meet cautious demand.
Methionine producers pushed prices higher this week, but downstream buying stayed measured, keeping overall market levels broadly stable despite stronger pricing intent.

🏭 Veterinary APIs remain in a consolidation phase.
With stockpiling largely completed, tylosin and tilmicosin are digesting inventories and trading within narrow ranges. At the same time, new EIA disclosures point to incremental API capacity additions worth monitoring.

👉 Click the image for the full market snapshot.
www.vegafeed.com

06/01/2026

📦 Valine holds firm on steady exports, while API projects advance steadily
Supply discipline supports amino acids as selective tightness appears in APIs
🧬 Amino Acids – Stable Offers, Export Support
Valine producers are delivering normally, with factory offers remaining stable. Trade market prices are in the range of USD 1.67–1.73/KG. As downstream buyers have largely completed earlier stock building, new bookings have slowed. However, overseas demand remains solid, providing support to the market. In the short term, prices are expected to stay firm, with close attention on inventory levels and production dynamics.

💊 APIs – Capacity Expansion & Firm Colistin
Zhejiang Shenzhou Pharmaceutical has received environmental impact assessment approval for its capacity expansion project, covering 20 MT/year of abiraterone acetate and 5 MT/year of norethindrone, with total investments of approximately USD 0.73 million and USD 0.58 million respectively.
Meanwhile, colistin sulfate supply is slightly tight, with prices holding firm at USD 14.36–14.62/KG. Short-term price stability is expected.

👉 Visit us: www.vegafeed.com

05/01/2026

🔎 Stable supply, cautious demand define today’s market tone.
Arginine prices held steady around USD 2.4/KG, but transaction volumes remained limited as end users replenished cautiously on a need-only basis. With ample supply and negotiated orders, short-term pricing is expected to stay weak yet stable.

🧬 Meanwhile, innovation advances on the API front.
A first-in-class nucleic-acid therapy for post-surgical liver cancer prevention has entered Phase II clinical trials, marking a notable milestone in high-end, immune-based drug development and highlighting continued momentum in cutting-edge pharmaceutical innovation.

👉 Click the image to explore the full market context.
www.vegafeed.com

23/10/2025

⚖️ Stability Before the Shift?
🧬 Amino Acid Market: Isoleucine prices stay steady at USD 2.80-2.93/kg, with weak downstream demand and limited restocking. Actual transactions are slightly lower, suggesting a narrow adjustment window ahead.
💊 API Market: Enrofloxacin and Ciprofloxacin HCl remain near recent lows — USD 20.32-20.94/kg and USD 18.07-19.32/kg, respectively. While demand has softened, the upcoming API Exhibition may bring new momentum and pricing signals.

👉 Stay updated at www.vegafeed.com
🌍

15/10/2025

New launch in Pakistan
SmartGlu (Rumen protected glucose)

Vega Group China & Hilton Pharma Pvt Ltd.

08/10/2025

https://www.vegafeed.com/ #/